bioRxivMolecular BiologyPreprint
Intronic polyadenylation isoforms in the 5' part of genes constitute a source of microproteins and are involved in cell response to cisplatin
Alexandre Devaux, Iris TanakaiD, Mandy Cadix, Amélie Heneman-MasureliD, Sophie MichalletiD, Quentin Fouilleul, Alina ChakrabortyiD, Céline M. Labbé, Nicolas Fontrodona, Jean‐Baptiste ClaudeiD, Marc DelogeriD, Pierre GestraudiD, Ludovic Tessier, Hussein Mortada, Sonia LameirasiD, Virginie RaynaliD, Sylvain BaulandeiD, Nicolas ServantiD, Didier AuboeufiD, Béatrice EyminiD, Stéphan VagneriD, Martin DutertreiD
Abstract
Transcript isoforms generated by intronic polyadenylation (IPA) are widely regulated in various biological processes and often encode protein isoforms. Microproteins are small proteins translated from small open reading frames (sORFs) in noncoding RNAs and mRNAs, but their production by IPA isoforms is unknown. Using 3-seq and long-read RNA-seq analyses in lung cancer cells, we show that cisplatin, a DNA-crosslinking anticancer agent, upregulates IPA isoforms relative to full-length mRNAs in long genes. A subset of cisplatin-regulated IPA isoforms are poorly associated with heavy polysomes and terminate upstream of the annotated translation initiation codon of genes. Such IPA isoforms in the PHF20 and PRKAR1B genes are associated with light polysomes, contain Ribo-Seq-supported sORFs in an alternative last exon within the annotated 5UTR part of genes, and are translated into microproteins. For PRKAR1B, the microprotein was detected by Western blot and immunofluorescence after transfection of a tagged isoform; and siRNA depletion of the endogenous IPA isoform, CRISPR deletion of the IPA site, or CRISPR mutation of the sORF initiation codon led to increased cell survival to cisplatin. Based on Ribo-Seq and mass-spectrometry data sets, we identified 156 genes producing both a canonical protein-coding mRNA and a microprotein-coding 5UTR-located IPA isoform (coined miP-5UTR-IPA isoform) regulated by cisplatin. Finally, the regulation of (miP-5UTR-)IPA versus full-length isoforms by cisplatin involved an inhibition of transcription processivity in a FANCD2 and senataxin-dependent manner. Altogether, these findings reveal the novel paradigm of miP-5UTR-IPA genes and their role in cancer cell response to a genotoxic agent. HIGHLIGHTS- Cisplatin increases intronic-polyadenylation versus full-length transcript isoforms in long genes through a FANCD2 and senataxin-dependent decrease of transcription processivity - A subset of cisplatin-regulated intronic-polyadenylation isoforms terminate in the annotated 5UTR part of genes and encode microproteins, thus we coined them miP-5UTR-IPA isoforms - The miP-5UTR-IPA isoform of PRKAR1B impacts cisplatin sensitivity and its effect is mediated by its small ORF - We identify 156 genes producing both a canonical protein-coding mRNA and a microprotein-coding miP-5UTR-IPA transcript
- organism: human
- assay: bulk RNA-seq
- assay: long-read sequencing
- assay: Ribo-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MET functions in tumour progression and therapy resistance are repressed by intronic polyadenylation
Galina Boldina, Maricarmen Vallejos, … Stéphan Vagner·bioRxiv·Aug 9, 2023
- A TP53 Intron-Derived Peptide Promotes Tumor Survival
Louis A. Cadena, Kevin Lee Luo, … Shih‐Han Lee·bioRxiv·Sep 4, 2025
- U1 snRNA blockade regulates DNA repair genes, DNA damage, and cisplatin sensitivity of lung cancer cells
Alexandre Devaux, Céline M. Labbé, … Martin Dutertre·bioRxiv·Aug 28, 2026
- A pan-cancer interrogation of intronic polyadenylation and its association with cancer characteristics
Liang Liu, Peiqing Sun, Wei Zhang·bioRxiv·Nov 14, 2022
- Minor intron splicing efficiency increases with the development of lethal prostate cancer
A. Augspach, K. Drake, … M. A. Rubin·bioRxiv·Dec 9, 2021
- CDK12 and CDK13 suppress distinct intronic polyadenylation sites
Molly J. Hulver, Andrew Polevoda, … Paul L. Boutz·bioRxiv·May 19, 2026